Doxazosin Tablet
Product Images NDC 51655-109

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 51655-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 109 52)

Doxazosin 4 mg tablets packaging label showing 30 tablets in the container. The label specifies the product is by Northwind Health Company, LLC and is prescription only. Storage instructions recommend 20°-25°C with excursions allowed between 15°-30°C, in the original container and out of children's reach. Additional product and lot details appear in smaller print.*

FDA Label Image

Table 1 (Doxazosin Fig1)

A data table titled 'Summary of Effectiveness Data in Placebo Controlled Trials' showing the change in symptom scores and maximum flow rate (mL/sec) across three studies comparing placebo to different doses of Doxazosin, including 4 mg and 8 mg. The table presents mean baseline and mean change values for symptom scores and maximum flow rates, alongside sample sizes. A bar chart on the right visually compares maximum flow rate and symptom score changes for placebo, 4 mg, and 8 mg doses, with statistical significance indicated.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line charts showing clinical trial data for Doxazosin versus placebo. The left chart depicts mean change in total symptom score from baseline over 14 weeks, showing greater symptom reduction with Doxazosin (n=50) than placebo (n=47). The right chart shows mean increase in maximum urinary flow rate (mL/sec) from baseline over the same period, with Doxazosin demonstrating a higher flow rate improvement compared to placebo.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure diagram of Doxazosin mesylate, depicting the molecular arrangement including aromatic rings, nitrogen atoms, and methoxy groups, illustrating the active pharmaceutical ingredient Doxazosin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.